ND Capital
NanoDimension is a venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed ND Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
NanoDimension is a leading venture capital firm investing in disruptive technologies in and at the convergence of the life and physical sciences. We focus on early stage opportunities in the US and Europe led by exceptional entrepreneurs. NanoDimension’s investment team takes an active approach to building portfolio companies, leveraging our expertise and network to find and build companies with innovative solutions to critical global problems.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2020 | Natron Energy | Series D | 0 |
| 2/2016 | ARMO BioSciences | Series C | 50M |
| 8/2017 | ARMO BioSciences | Series C | 0 |
| 10/2016 | Emulate | Series B | 0 |
| 11/2007 | BIND Therapeutics | Series B | 16M |
| 4/2019 | Inscripta | Series C | 0 |
| 2/2018 | H55 | Venture Round | - |
| 5/2010 | Crocus Technology | Series C | 0 |
| 6/2012 | View | Series D | 0 |
| 1/2016 | Pulse Therapeutics | Venture Round | 10M |
| 7/2014 | Emulate | Series A | 12M |
| 7/2013 | Crocus Technology | Series D | 0 |
| 4/2010 | Selecta Biosciences | Series C | 15M |
| 1/2016 | Twist Bioscience | Series D | 61M |
| 1/2015 | Tarveda Therapeutics | Series B | 21M |
| 2/2017 | Inscripta | Series B | 23M |
| 1/2012 | Tarveda Therapeutics | Series A | 2.8M |
| 5/2014 | ARMO BioSciences | Series B | 30M |
| 6/2015 | Crocus Technology | Series E | 21M |
| 11/2013 | View | Venture Round | 12.6M |
| 10/2008 | Crocus Technology | Series B | 15.9M |
| 7/2018 | Serotiny | Seed Round | 3M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 12/2013 | Tarveda Therapeutics | Series B | 21M |
| 6/2010 | BIND Therapeutics | Series C | 12.4M |
| 5/2020 | SQZ Biotech | Series D | 0 |
| 2/2009 | Selecta Biosciences | Series B | 15.1M |
| 9/2015 | Selecta Biosciences | Series E | 38M |
| 10/2014 | Selecta Biosciences | Private Equity Round | 20M |
| 9/2016 | SQZ Biotech | Series B | 16M |
| 4/2021 | Icosavax | Series B | 0 |
| 12/2010 | View | Series C | 40M |
| 2/2017 | Tarveda Therapeutics | Series D | 30M |
| 3/2008 | Xtellus | Venture Round | 8.3M |
| 12/2019 | Arctos Medical | Seed Round | 0 |
| 5/2014 | Twist Bioscience | Series B | 26M |
| 12/2018 | Inscripta | Series C | 0 |
| 2/2018 | Inscripta | Series C | 55.5M |
| 8/2018 | SQZ Biotech | Series C | 0 |
| 10/2019 | Icosavax | Series A | 0 |
| 1/2010 | SBA Materials | Venture Round | 5.2M |
| 6/2015 | Twist Bioscience | Series C | 37M |
| 4/2021 | Icosavax | Series B | 0 |
| 7/2020 | Natron Energy | Series D | 0 |
| 5/2020 | SQZ Biotech | Series D | 0 |
| 12/2019 | Arctos Medical | Seed Round | 0 |
| 10/2019 | Icosavax | Series A | 0 |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 4/2019 | Inscripta | Series C | 0 |
| 12/2018 | Inscripta | Series C | 0 |
| 8/2018 | SQZ Biotech | Series C | 0 |
| 7/2018 | Serotiny | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
